NCT07054619
- Conditions
- First Aid Training, Hemic and Lymphatic Diseases, Immune System Diseases, +17 more
- Locations
-
- Burdur Mehmet Akif Ersoy University Faculty of Health Science Burdur, Center, Turkey (Türkiye)
Clinical trial condition
Lymphoproliferative Disorders
Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.
10,119 public trials
2,034 recruiting studies
Lymphoproliferative Disorders trial results
Completed
Granzyme B PET Imaging Drug as a Predictor of Immunotherapy Response to Checkpoint Inhibitors
NCT04169321
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
- Chang-Gung Memorial Hospital Taoyuan City, Guishan, Taiwan
NCT04970992
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
- Locations
-
- Cedars-Sinai Medical Center Los Angeles, California, United States
NCT02195479
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- California City, California, United States
- Corona, California, United States
- Fountain Valley, California, United States
- Los Angeles, California, United States
NCT05950334
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Advent Health Orlando, Florida, United States
- Karmanos Cancer Center Detroit, Michigan, United States
- University of Minnesota Masonic Cancer Center Minneapolis, Minnesota, United States
- University of Nebraska Medical Center Omaha, Nebraska, United States
NCT02998476
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Banner MD Anderson Cancer Center Gilbert, Arizona, United States
- Arizona Oncology Associates, PC - HAL Tempe, Arizona, United States
- Sutter Gould Medical Foundation Modesto, California, United States
NCT03424122
- Conditions
- B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
- Locations
-
- University of Arizona Cancer Center - Out Pt. Tucson, Arizona, United States
- Indiana Blood and Marrow Transplantation Indianapolis, Indiana, United States
- Comprehensive Cancer Center of Nevada Las Vegas, Nevada, United States
- Texas Oncology Austin, Texas, United States
NCT03039114
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- Banner Health Gilbert, Arizona, United States
- University of California, San Diego La Jolla, California, United States
- University of Kansas Cancer Center Fairway, Kansas, United States
- Center for Cancer and Blood Disorders (CCBD) - Bethesda Bethesda, Maryland, United States
Completed
A Study of the MALT1 Inhibitor JNJ-67856633 and Ibrutinib in Combination in B-cell NHL and CLL
NCT04876092
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +15 more
- Locations
-
- Rigshospitalet Copenhagen, Denmark
- CHRU de Lille Hopital Claude Huriez Lille, France
- Institut Paoli Calmettes Marseille, France
- CHU de Nantes hotel Dieu Nantes, France
Completed
A Study of JNJ-64264681 in Participants With Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia
NCT04210219
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +15 more
- Locations
-
- Icahn School of Medicine at Mount Sinai New York, United States
- Arensia Exploratory Medicine Tbilisi, Georgia
- Arensia Exploratory Medicine Chisinau, Moldova
- Uniwersyteckie Centrum Kliniczne Gdansk, Poland